Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain stability for pharmaceutical manufacturing.
Patent CN115233243B reveals green electrocatalytic synthesis for oxazoles. Eliminates noble metals, reduces cost, ensures supply chain stability for pharma intermediates.
Novel water-based method for quinoxaline synthesis offers cost-effective, scalable production for pharmaceutical intermediates with high purity and environmental compliance.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.
Novel metal-free synthesis route for fluorinated heterocycles. Reduces cost and complexity for pharma intermediate manufacturing with high stereoselectivity.
Patent CN113121462B reveals a metal-free, azide-free route for 5-trifluoromethyl-1,2,3-triazoles, offering significant cost reduction in API manufacturing and enhanced supply chain safety.
Patent CN119823040A reveals a novel Pd-catalyzed route for heterocyclic synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115260188B details cobalt-catalyzed carbonylation for tetrahydro-beta-carboline ketones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN110746278B reveals a mild, non-metal route for 1,3-diketones. Achieve high purity and cost reduction in API manufacturing without precious metal catalysts.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Novel Pd-catalyzed serial cyclization offers high-purity beta-halopyrrole intermediates with simplified purification and scalable manufacturing capabilities.
Patent CN113307790B reveals a metal-free oxidative cyclization route for 1,2,4-triazole intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN114920707B reveals a novel DMF-based synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and simplified supply chains.
Patent CN113880781B reveals glucose-based triazole synthesis offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability for global buyers.
Novel palladium-catalyzed carbonylation method for indolo[2,1a]isoquinoline. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel nickel-catalyzed carbonylation method for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed synthesis offers cost reduction in fine chemical manufacturing. High-purity amide compounds with scalable production capabilities for global supply chains.